[go: up one dir, main page]

KR20020067701A - 3-아미노퀴나졸린-2,4-디온 항균제 - Google Patents

3-아미노퀴나졸린-2,4-디온 항균제 Download PDF

Info

Publication number
KR20020067701A
KR20020067701A KR1020027009515A KR20027009515A KR20020067701A KR 20020067701 A KR20020067701 A KR 20020067701A KR 1020027009515 A KR1020027009515 A KR 1020027009515A KR 20027009515 A KR20027009515 A KR 20027009515A KR 20020067701 A KR20020067701 A KR 20020067701A
Authority
KR
South Korea
Prior art keywords
dione
amino
cyclopropyl
fluoro
quinazoline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020027009515A
Other languages
English (en)
Korean (ko)
Inventor
폴 버드
에드먼드 리 엘스워쓰
다이 쿼크 은구옌
죠세프 피터 산체즈
하워드 다니엘 홀리스 쇼우알터
라제시와 싱히
마이클 앤드류 스티어
투안 퐁 트랜스
브라이언 모르간 왓슨
쥬디 이프
Original Assignee
워너-램버트 캄파니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 워너-램버트 캄파니 filed Critical 워너-램버트 캄파니
Publication of KR20020067701A publication Critical patent/KR20020067701A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/95Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • C07D239/96Two oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Paper (AREA)
KR1020027009515A 2000-01-24 2000-12-12 3-아미노퀴나졸린-2,4-디온 항균제 Withdrawn KR20020067701A (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US17825200P 2000-01-24 2000-01-24
US60/178,252 2000-01-24
US24126700P 2000-10-18 2000-10-18
US60/241,267 2000-10-18
PCT/US2000/033656 WO2001053273A1 (en) 2000-01-24 2000-12-12 3-aminoquinazolin-2,4-dione antibacterial agents

Publications (1)

Publication Number Publication Date
KR20020067701A true KR20020067701A (ko) 2002-08-23

Family

ID=26874138

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020027009515A Withdrawn KR20020067701A (ko) 2000-01-24 2000-12-12 3-아미노퀴나졸린-2,4-디온 항균제

Country Status (38)

Country Link
US (2) US7094780B1 (es)
EP (1) EP1255739B1 (es)
JP (1) JP4811978B2 (es)
KR (1) KR20020067701A (es)
CN (1) CN1425008A (es)
AP (1) AP2002002603A0 (es)
AR (1) AR030186A1 (es)
AT (1) ATE398110T1 (es)
AU (1) AU783078B2 (es)
BG (1) BG107023A (es)
BR (1) BR0017010A (es)
CA (1) CA2393802C (es)
CO (1) CO5320600A1 (es)
CR (1) CR6709A (es)
DE (1) DE60039194D1 (es)
EA (1) EA005585B1 (es)
EE (1) EE200200412A (es)
ES (1) ES2304992T3 (es)
GE (1) GEP20053429B (es)
HK (1) HK1054237A1 (es)
HN (1) HN2001000009A (es)
HR (1) HRP20020696A2 (es)
HU (1) HUP0204101A3 (es)
IL (1) IL150393A0 (es)
IS (1) IS6448A (es)
MA (1) MA26866A1 (es)
MX (1) MXPA02005989A (es)
NO (1) NO20023516D0 (es)
OA (1) OA12316A (es)
PA (1) PA8510101A1 (es)
PE (1) PE20011060A1 (es)
PL (1) PL356837A1 (es)
SK (1) SK10572002A3 (es)
SV (1) SV2001000288A (es)
TN (1) TNSN01011A1 (es)
UY (1) UY26551A1 (es)
WO (1) WO2001053273A1 (es)
YU (1) YU55902A (es)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU735186B2 (en) 1997-09-15 2001-07-05 Warner Chilcott Company, Llc Antimicrobial quinolones, their compositions and uses
MXPA03010799A (es) 2001-05-30 2005-07-25 Warner Lambert Co Agentes antibacterianos.
MXPA03009894A (es) * 2001-06-19 2004-02-17 Warner Lambert Co Agentes antibacterianos.
US6900224B2 (en) * 2002-07-31 2005-05-31 The Procter & Gamble Company Antimicrobial quinolones, their compositions and uses
EP1667994A1 (en) * 2003-09-12 2006-06-14 Warner-Lambert Company LLC Quinolone antibacterial agents
WO2005026153A1 (en) * 2003-09-12 2005-03-24 Warner-Lambert Company Llc Quinazoline-2, 4-diones as antibacterial agents
BRPI0416708A (pt) * 2003-11-18 2007-01-16 Warner Lambert Co derivados de aminoquinazolidinadiona antibacterianos
WO2006019965A2 (en) * 2004-07-16 2006-02-23 Takeda San Diego, Inc. Dipeptidyl peptidase inhibitors
GB0416730D0 (en) 2004-07-27 2004-09-01 Novartis Ag Organic compounds
ATE447572T1 (de) * 2005-01-26 2009-11-15 Hoffmann La Roche Phenylmethanonderivate und ihre verwendung als glycin-transporter-1-hemmer
GB0507298D0 (en) * 2005-04-11 2005-05-18 Novartis Ag Organic compounds
US7977346B2 (en) 2006-01-17 2011-07-12 Guoqing Paul Chen Spiro compounds and methods of use
KR101084521B1 (ko) 2006-03-28 2011-11-18 워너 칠콧 컴퍼니 엘엘씨 퀴놀론 중간체를 제조하기 위한 커플링 방법
DK2001862T3 (da) 2006-03-28 2011-08-08 Warner Chilcott Co Llc Malatsalte og polymorfe af (3S,5S)-7-[3-amino-5-methyl-piperidinyl]-1-cyklopropyl-1,4-dihydro-8-methoxy-4-oxo-3-quinolincarboxylsyre
US20080139574A1 (en) 2006-11-30 2008-06-12 Cadila Healthcare Limited Novel quinoline derivatives
PT2239257E (pt) * 2008-01-30 2012-09-12 Shin Poong Pharmaceutical Co Ltd Novo derivado de quinazolina-2,4-diona e composições médicas para a profilaxia e tratamento da doença dos nervos cranianos contendo o dito derivado
WO2011031745A1 (en) 2009-09-09 2011-03-17 Achaogen, Inc. Antibacterial fluoroquinolone analogs
US8754114B2 (en) 2010-12-22 2014-06-17 Incyte Corporation Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3
MX345780B (es) 2011-03-15 2017-02-15 Trius Therapeutics Inc Inhibidores triciclicos de girasa.
CN103415520B8 (zh) * 2011-12-21 2017-04-05 江苏恒瑞医药股份有限公司 吡咯并六元杂芳环类衍生物、其制备方法及其在医药上的应用
DK2861595T5 (en) 2012-06-13 2018-01-15 Incyte Holdings Corp Substituted tricyclic compounds as FGFR inhibitors
WO2014026125A1 (en) 2012-08-10 2014-02-13 Incyte Corporation Pyrazine derivatives as fgfr inhibitors
EP2895488B1 (en) 2012-09-12 2024-12-11 Merck Sharp & Dohme LLC Tricyclic gyrase inhibitors for use as antibacterial agents
US9266892B2 (en) 2012-12-19 2016-02-23 Incyte Holdings Corporation Fused pyrazoles as FGFR inhibitors
MY181497A (en) 2013-04-19 2020-12-23 Incyte Holdings Corp Bicyclic heterocycles as fgfr inhibitors
US10851105B2 (en) 2014-10-22 2020-12-01 Incyte Corporation Bicyclic heterocycles as FGFR4 inhibitors
MA41551A (fr) 2015-02-20 2017-12-26 Incyte Corp Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4
US9580423B2 (en) 2015-02-20 2017-02-28 Incyte Corporation Bicyclic heterocycles as FGFR4 inhibitors
AU2016219822B2 (en) 2015-02-20 2020-07-09 Incyte Holdings Corporation Bicyclic heterocycles as FGFR inhibitors
CN108530448A (zh) * 2017-03-02 2018-09-14 浙江司太立制药股份有限公司 含有碱性氮杂螺环片段的苯并噻嗪-4-酮类化合物及其制备方法
AR111960A1 (es) 2017-05-26 2019-09-04 Incyte Corp Formas cristalinas de un inhibidor de fgfr y procesos para su preparación
MA52493A (fr) 2018-05-04 2021-03-10 Incyte Corp Sels d'un inhibiteur de fgfr
JP2021523121A (ja) 2018-05-04 2021-09-02 インサイト・コーポレイションIncyte Corporation Fgfr阻害剤の固体形態及びその調製プロセス
CN111620866A (zh) * 2019-02-27 2020-09-04 南京药石科技股份有限公司 一种顺式-7,7-二氟-六氢-1H 吡咯并[3,4-c]吡啶衍生物及其制备方法
WO2020185532A1 (en) 2019-03-08 2020-09-17 Incyte Corporation Methods of treating cancer with an fgfr inhibitor
WO2021007269A1 (en) 2019-07-09 2021-01-14 Incyte Corporation Bicyclic heterocycles as fgfr inhibitors
WO2021067374A1 (en) 2019-10-01 2021-04-08 Incyte Corporation Bicyclic heterocycles as fgfr inhibitors
AU2020366006A1 (en) 2019-10-14 2022-04-21 Incyte Corporation Bicyclic heterocycles as FGFR inhibitors
WO2021076728A1 (en) 2019-10-16 2021-04-22 Incyte Corporation Bicyclic heterocycles as fgfr inhibitors
EP4069696A1 (en) 2019-12-04 2022-10-12 Incyte Corporation Tricyclic heterocycles as fgfr inhibitors
CN115151539A (zh) 2019-12-04 2022-10-04 因赛特公司 Fgfr抑制剂的衍生物
US12012409B2 (en) 2020-01-15 2024-06-18 Incyte Corporation Bicyclic heterocycles as FGFR inhibitors
CN111499513B (zh) * 2020-04-24 2023-03-14 上海毕得医药科技股份有限公司 一种2,3,4,5-四溴苯甲酸酯的合成方法
US12065494B2 (en) 2021-04-12 2024-08-20 Incyte Corporation Combination therapy comprising an FGFR inhibitor and a Nectin-4 targeting agent
WO2022261160A1 (en) 2021-06-09 2022-12-15 Incyte Corporation Tricyclic heterocycles as fgfr inhibitors

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1068263B (es) * 1959-11-05
FR1203542A (fr) * 1958-02-25 1960-01-19 Rhone Poulenc Sa Nouveaux dérivés de la phénothiazine comportant en position 10 une chaîne pipérazinique et leurs procédés de préparation
EP0035619B1 (fr) * 1980-03-10 1984-07-25 BERRI-BALZAC Société dite: Dérivés d'amino-3 (1H,3H) quinazolinedione-2,4
GB2097784A (en) * 1981-04-28 1982-11-10 Davidson Dr John Stirton Dihydrobenzotriazepine diones; aminoquinazoline diones
AU5813394A (en) 1992-12-23 1994-07-19 Byk Gulden Lomberg Chemische Fabrik Gmbh Anellated uracil derivates
WO1998018781A2 (en) 1996-10-28 1998-05-07 Versicor, Inc. Fused 2,4-pyrimidinedione combinatorial libraries, their preparation and the use of fused 2,4-pyrimidinediones derivatives as antimicrobial agents
EP1028950B1 (en) 1997-10-28 2003-05-02 Warner-Lambert Company LLC 7-substituted quinazolin-2,4-diones useful as antibacterial agents
ID27589A (id) * 1998-05-26 2001-04-12 Warner Lambert Comapny Pirimidina bisiklik dan dihidropirimidina bisiklik 3,4 sebagai penghambat proliferasi selular
EP1137640B1 (en) * 1998-12-11 2005-09-21 F. Hoffmann-La Roche Ag Cyclic hydrazine derivatives as tnf-alpha inhibitors

Also Published As

Publication number Publication date
PL356837A1 (en) 2004-07-12
EP1255739A1 (en) 2002-11-13
TNSN01011A1 (en) 2005-11-10
ATE398110T1 (de) 2008-07-15
ES2304992T3 (es) 2008-11-01
US7582627B2 (en) 2009-09-01
CR6709A (es) 2003-11-25
CA2393802C (en) 2011-04-19
DE60039194D1 (de) 2008-07-24
JP2003520277A (ja) 2003-07-02
WO2001053273A1 (en) 2001-07-26
AU2089901A (en) 2001-07-31
PA8510101A1 (es) 2003-06-30
NO20023516L (no) 2002-07-23
US20060183762A1 (en) 2006-08-17
YU55902A (sh) 2006-01-16
IS6448A (is) 2002-06-27
BG107023A (en) 2003-04-30
MA26866A1 (fr) 2004-12-20
MXPA02005989A (es) 2002-10-23
UY26551A1 (es) 2001-04-30
US7094780B1 (en) 2006-08-22
HK1054237A1 (zh) 2003-11-21
EA200200661A1 (ru) 2003-02-27
EP1255739B1 (en) 2008-06-11
HUP0204101A2 (hu) 2003-04-28
JP4811978B2 (ja) 2011-11-09
IL150393A0 (en) 2002-12-01
PE20011060A1 (es) 2001-10-12
SV2001000288A (es) 2001-11-30
OA12316A (en) 2006-05-15
US20060287308A1 (en) 2006-12-21
AP2002002603A0 (en) 2002-09-30
HUP0204101A3 (en) 2004-05-28
BR0017010A (pt) 2002-11-05
CO5320600A1 (es) 2003-09-30
EE200200412A (et) 2003-10-15
HN2001000009A (es) 2001-06-13
EA005585B1 (ru) 2005-04-28
GEP20053429B (en) 2005-01-25
AU783078B2 (en) 2005-09-22
CA2393802A1 (en) 2001-07-26
CN1425008A (zh) 2003-06-18
SK10572002A3 (sk) 2003-10-07
NO20023516D0 (no) 2002-07-23
AR030186A1 (es) 2003-08-13
HRP20020696A2 (en) 2003-12-31

Similar Documents

Publication Publication Date Title
KR20020067701A (ko) 3-아미노퀴나졸린-2,4-디온 항균제
EP3414234B1 (en) Bruton's tyrosine kinase inhibitors
EP2789614B1 (en) Azaindazoles as Btk kinase modulators and use thereof
EP3122731B1 (en) Cyclohexylmethansulfonamides
US9956220B2 (en) Imidazo-pyridazine derivatives as casein kinase 1 δ/ϵ inhibitors
TW200403245A (en) Pyrrolopyridazine compounds and methods of use thereof for the treatment of proliferative disorders
US6825199B2 (en) 7-Substituted quinazolin-2,4-diones useful as antibacterial agents
PL221339B1 (pl) Nowe pochodne pirolu jako środki farmaceutyczne
HU196986B (en) Process for producing new naphtiridine- and quinoline-carboxylic acids of antibacterial activity and pharmaceutical compositions containing them
JP2005501021A (ja) 抗細菌剤
KR20180135885A (ko) 브루톤 티로신 키나제 억제제
KR20080080211A (ko) 항박테리아성 피롤로피리딘, 피롤로피리미딘 및피롤로아제핀
KR20230157432A (ko) 야누스 키나아제 억제제로서 헤테로사이클릭 유도체
EP3313852B1 (en) Substituted pyrazolo/imidazolo bicyclic compounds as pde2 inhibitors
EP3302486B1 (en) Dihydropyrazolopyrimidinone compounds as pde2 inhibitors
CN113292561A (zh) 一种二吡咯并吡啶结构的化合物、制备方法和医药用途
US20030114666A1 (en) Antibacterial agents
ES2771151T3 (es) Derivados de piperidina como inhibidor de señalización wnt
JP2022514300A (ja) 細菌感染症の処置および予防のためのオキソピリド[1,2-a]ピリミジン化合物

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20020724

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid